Skip to main content

CNN Health

FDA approves new drug for patients with metastatic breast cancer

6 years 5 months ago
The US Food and Drug Administration has approved the use of the drug tucatinib, or Tukysa, in combination with chemotherapy, for the treatment of adults with advanced forms of HER2-positive breast cancer that either cannot be removed with surgery, or has spread to other parts of the body, including the brain.
Checked
50 seconds ago
CNN Health
Google News sitemap — sections: health
Subscribe to CNN Health feed